Lv31
388 积分 2023-11-21 加入
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
5小时前
待确认
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
8小时前
已完结
Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia
25天前
已完结
A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)
25天前
已完结
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
1个月前
已完结
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
1个月前
已完结
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
1个月前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
1个月前
已完结
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
